Jasper Therapeutics Inc - Class A —— 资产负债表 (NASDAQ:JSPR) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 101.26 M93.65 M48.36 M94.89 M79.9 M35.78 M 负债总额 3.77 M24.14 M12.37 M16.45 M18.23 M31.63 M 权益总额 5 M69.52 M35.99 M78.44 M61.67 M4.15 M 负债及股东权益总额 101.26 M93.65 M48.36 M94.89 M79.9 M35.78 M 总债务 -444.77 K————1.64 M 净债务 -1.21 M————-27.06 M

新闻

Rodman & Renshaw 给予 Jasper Therapeutics 股票买入评级

Rodman & Renshaw initiates Jasper Therapeutics stock with Buy rating

Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies in Chronic Urticaria - Slideshow (NASDAQ:JSPR) 2026-01-11

公民维持Jasper Therapeutics股票评级为"市场表现优于大盘"

Jasper Therapeutics stock rating reiterated at Market Outperform by Citizens

Jasper公布briquilimab治疗慢性荨麻疹的积极试验数据

Jasper reports positive data from briquilimab trials in chronic urticaria

捷斯珀治疗股价在领导层变动后上涨

Jasper Therapeutics stock rises after leadership changes

Jasper Therapeutics任命Jeet Mahal为CEO进行领导层过渡

Jasper Therapeutics appoints Jeet Mahal as CEO in leadership transition

Jasper Therapeutics, Inc. (JSPR) Discusses Investigation Into BEACON Study Anomalies and Preliminary ETESIAN Asthma Data - Slideshow (NASDAQ:JSPR) 2025-12-04